Arnab Ray Chaudhuri

Arnab Ray Chaudhuri

Auto-generated profile, based on publicly available information

Arnab Ray Chaudhuri

Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2017 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
ACArnab Ray Chaudhuri
Arnab Ray Chaudhuri
ANAndré Nussenzweig
André Nussenzweig

23 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
CMChirantani Mukherjee
Chirantani Mukherjee
VTVivek Tripathi
Vivek Tripathi
EMEleni Maria Manolika
Eleni Maria Manolika
AHAnne Margriet Heijink
Anne Margriet Heijink
GRGiulia Ricci
Giulia Ricci
ACArnab Ray Chaudhuri
Arnab Ray Chaudhuri
Homologous recombination (HR) and Fanconi Anemia (FA) pathway proteins in addition to their DNA repair functions, limit nuclease-mediated processing of stalled replication forks. However, the mechanism by which replication fork degradation results in genome instability is poorly understood. Here, we identify RIF1, a non-homologous end joining (NHEJ) factor, to be enriched at stalled replication forks. Rif1 knockout cells are proficient for recombination, but displayed degradation of reversed forks, which depends on DNA2 nuclease activity. Notably, RIF1-mediated protection of replication forks is independent of its function in NHEJ, but depends on its interaction with Protein Phosphatase 1. RIF1 deficiency delays fork restart and results in exposure of under-replicated DNA, which is the precursor of subsequent genomic instability. Our data implicate RIF1 to be an essential factor for replication fork protection, and uncover the mechanisms by which unprotected DNA replication forks can lead to genome instability in recombination-proficient conditions.

22 September 2021 in Molecular Cell
Verified
Journal Article
Closed access
MDMariana Paes Dias
Mariana Paes Dias
VTVivek Tripathi
Vivek Tripathi
IHIngrid van der Heijden
Ingrid van der Heijden
KCKe Cong
Ke Cong
EMEleni-Maria Manolika
Eleni-Maria Manolika
JJJos Jonkers
Jos Jonkers

5 February 2024 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
AMALICE MERONI
ALICE MERONI
SWSophie E. Wells
Sophie E. Wells
CFCarmen Fonseca
Carmen Fonseca
ACArnab Ray Chaudhuri
Arnab Ray Chaudhuri
KCKeith W. Caldecott
Keith W. Caldecott
AVAlessandro Vindigni
Alessandro Vindigni
DNA combing and DNA spreading are two central approaches for studying DNA replication fork dynamics genome-wide at single-molecule resolution by distributing labeled genomic DNA on coverslips or slides for immunodetection. Perturbations in DNA replication fork dynamics can differentially affect either leading or lagging strand synthesis, for example, in instances where replication is blocked by a lesion or obstacle on only one of the two strands. Thus, we sought to investigate whether the DNA combing and/or spreading approaches are suitable for resolving adjacent sister chromatids during DNA replication, thereby enabling the detection of DNA replication dynamics within individual nascent strands. To this end, we developed a thymidine labeling scheme that discriminates between these two possibilities. Our data suggests that DNA combing resolves sister chromatids, allowing the detection of strand-specific alterations, whereas DNA spreading typically does not. These findings have important implications when interpreting DNA replication dynamics from data obtained by these two commonly used techniques.

30 October 2025 in Science
Verified
Journal Article
Closed access
RKRaviprasad Kuthethur
Raviprasad Kuthethur
SVSafa Nasrin Vz
Safa Nasrin Vz
SSSatheesh Kumar Sengodan
Satheesh Kumar Sengodan
CFCarmen Fonseca
Carmen Fonseca
SBStefan Braunshier
Stefan Braunshier
ACArnab Ray Chaudhuri
Arnab Ray Chaudhuri
Homologous recombination (HR) deficiency upon Breast Cancer Gene 2 (BRCA2) loss arises from defects in the formation of RAD51 nucleoprotein filaments. We demonstrate that loss of the anti-recombinase Fidgetin Like 1 (FIGNL1) retains RAD51 loading at DNA double-stranded breaks (DSBs) in BRCA2-deficient cells, leading to genome stability, HR proficiency, and viability of BRCA2-deficient mouse embryonic stem cells. Mechanistically, we demonstrate that strand invasion and subsequent HR defects upon BRCA2 loss primarily arise from the unrestricted removal of RAD51 from DSB sites by FIGNL1, rather than from defective RAD51 loading. Furthermore, we identify that the MMS22L-TONSL complex interacts with FIGNL1 and is critical for HR in BRCA2/FIGNL1 double-deficient cells. These findings identify a pathway for tightly regulating RAD51 activity to promote efficient HR, offering insights into mechanisms of chemoresistance in BRCA2-deficient tumors.

23 August 2017 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
ACArnab Ray Chaudhuri
Arnab Ray Chaudhuri
ANAndré Nussenzweig
André Nussenzweig
Homologous recombination (HR) and the Fanconi Anemia (FA) pathways constitute essential repair pathways for DNA damage, which includes DNA double‐stranded breaks (DSB) and inter‐strand cross‐links (ICL), respectively. Germline mutations affecting a single copy of the HR factors BRCA1 and BRCA2 predispose individuals to cancers of the breast, ovary, prostate, and pancreas. Cells deficient for BRCA proteins display high levels of genome instability due to defective repair of endogenous DSBs and are also exquisitely sensitive to DNA‐damaging agents. In addition to their roles in repair of DSBs and ICLs, HR and FA proteins have a genetically separable function in the protection of stalled DNA replication forks from nuclease‐mediated degradation (Schlacher et al , 2012). Although it has been hypothesized that loss of functional HR and ICL repair is the primary cause of cancer in BRCA‐ and FA‐deficient patients (Prakash et al , 2015), the contribution of replication fork instability associated with the degradation of nascent DNA remains unclear. Two recent papers explain how endogenous toxins render cells vulnerable to genomic instability, which explains how the BRCA/FA pathway suppresses tumorigenesis (Tacconi et al , 2017; Tan et al , 2017).